Literature DB >> 14700414

Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance.

Ioannis Chatzinikolaou1, Hend Hanna, Linda Graviss, Gassan Chaiban, Cheryl Perego, Rebecca Arbuckle, Richard Champlin, Rabih Darouiche, George Samonis, Issam Raad.   

Abstract

In this retrospective evaluation of the 4-year clinical use of minocycline and rifampin-impregnated catheters in bone marrow transplantation (BMT) patients, we report low risk of development of staphylococcal resistance to the antibiotics coating the catheters and efficacy in preventing primary staphylococcal bloodstream infections.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14700414     DOI： 10.1086/502167

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  6 in total

1.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

2.  Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial.

Authors:  Rabih O Darouiche; David H Berger; Nancy Khardori; Claudia S Robertson; Matthew J Wall; Michael H Metzler; Seema Shah; Mohammad D Mansouri; Colleen Cerra-Stewart; James Versalovic; Michael J Reardon; Issam I Raad
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

3.  Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters.

Authors:  Hend Hanna; Paul Bahna; Ruth Reitzel; Tanya Dvorak; Gassan Chaiban; Ray Hachem; Issam Raad
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

4.  Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters.

Authors:  I Raad; R Hachem; H Hanna; P Bahna; I Chatzinikolaou; X Fang; Y Jiang; R F Chemaly; K Rolston
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

Review 5.  The potential for developing new antimicrobial resistance from the use of medical devices containing chlorhexidine, minocycline, rifampicin and their combinations: a systematic review.

Authors:  Ruth A Reitzel; Joel Rosenblatt; Bahgat Z Gerges; Andrew Jarjour; Ana Fernández-Cruz; Issam I Raad
Journal:  JAC Antimicrob Resist       Date:  2020-02-21

6.  Prophylactic administration of doxycycline reduces central venous catheter infections in patients undergoing hematopoietic cell transplantation.

Authors:  Mohamed Baydoun; Zaher K Otrock; Samar Okaily; Rita Nehme; Racha Abu-Chahine; Ali Hamdan; Samar Noureddine; Souha Kanj; Zeina Kanafani; Ali Bazarbachi; Mohamed A Kharfan-Dabaja
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-02-16       Impact factor: 2.576
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.